Role of the Immune Environment in Response to Therapy in Breast Cancer
Recruiting · NCT05396612 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
What this trial is about
This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Women 18 years of age or older with non-metastatic breast cancer undergoing surgical resection in the University of Pennsylvania Health System.
Exclusion criteria
- Males Children Pregnant individuals
Where it is running
1 location listed across 1 US state.
- Abramson Cancer Center - Philadelphia, Pennsylvania, United States